How do I find clinical trials for Pancreatic Cancer

Pancreatic CancerMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Finding Clinical Trials for Pancreatic Cancer

Finding the right clinical trial can be an important part of your pancreatic cancer treatment plan. Here's a practical guide to help you navigate your options.

Why Clinical Trials Matter for Pancreatic Cancer

According to the NCCN Guidelines for Patients: Pancreatic Cancer, clinical trials are particularly important because current standard treatments often aren't effective long-term. As the guidelines emphasize, "advances in the treatment of pancreatic cancer were made possible by clinical trials. Yet better treatment is still needed."

In fact, Let's Win Pancreatic Cancer notes that clinical trials should be considered from the very start of your treatment—not just as a last resort. This is especially important because pancreatic cancer is often diagnosed at an advanced stage, and participating in a trial may give you access to cutting-edge treatments today rather than waiting years for them to become widely available.

Online Resources to Search for Trials

1. ClinicalTrials.gov (National Institutes of Health)

  • The most comprehensive database of clinical trials
  • You can search by cancer type, location, and stage
  • Provides detailed information about each trial's requirements and what's involved

2. Let's Win Trial Finder (Pancreatic Cancer Action Network)

  • Specifically designed for pancreatic cancer patients
  • Easier to navigate than general databases
  • Tailored to pancreatic cancer-specific trials

3. Massive Bio and myTomorrows

  • Free services that review your [ID removed]
  • Make personalized recommendations for trials you may qualify for
  • Consider your specific location and medical situation

4. Pancreatic Cancer Action Network (PanCAN)

  • Educational resources about clinical trials
  • Information about how trials work and what to expect

What to Do Next: Questions to Ask Your Doctor

According to the NCCN Guidelines, you should actively discuss clinical trials with your healthcare team. Here are specific questions to ask:

  1. "Do you recommend that I consider a clinical trial for treatment?"

    • Your doctor may know about trials not listed online
  2. "Have you done molecular profiling (genetic testing) on my tumor?"

    • This is now recommended in national guidelines and can open up targeted therapy trials
    • Ask to see the report and keep a copy for yourself
  3. "What clinical trials am I eligible for based on my stage and tumor genetics?"

    • Eligibility depends on your specific cancer characteristics
  4. "What are the treatments used in the clinical trial, and what are the risks and benefits?"

    • Understand what you'd be receiving
  5. "How long will I be in the clinical trial, and will I be able to get other treatment if this doesn't work?"

    • Important for planning and understanding your options
  6. "What side effects should I expect and how will they be managed?"

    • Know what to prepare for
  7. "Will the clinical trial cost me anything?"

    • Treatments in trials are typically covered, but travel and extra visits may have costs

Important Things to Know About Pancreatic Cancer Trials

Standard of Care Plus Approach According to Let's Win Pancreatic Cancer, think of clinical trials as "standard of care plus." This means:

  • You'll still receive the best current treatment available
  • The trial adds a new therapy on top of standard treatment
  • You're not sacrificing proven treatments to participate

Unique Challenges for Pancreatic Cancer Patients Be aware that pancreatic cancer trials can have stricter eligibility requirements because:

  • Pancreatic cancer causes scar tissue (fibrosis) that makes biopsies difficult
  • Patients often have more symptoms than other cancer types (neuropathy, malnutrition, muscle loss)
  • Many patients are diagnosed at advanced stages when they're sicker
  • Some trials require specific biomarkers or genetic mutations

Getting a Second Opinion Let's Win Pancreatic Cancer recommends getting a second opinion from a major academic medical center. These centers:

  • Often have access to cutting-edge trials
  • Have oncologists who specialize in pancreatic cancer
  • Stay current with the latest research and treatment options

The Trial Process

According to the NCCN Guidelines, most cancer clinical trials focus on treatment and are done in phases:

  • Phase 1: Tests safety and side effects; looks for early signs the drug works
  • Phase 2: Studies how well the drug works against pancreatic cancer
  • Phase 3: Tests the drug against standard treatment; if results are good, may lead to FDA approval
  • Phase 4: Studies long-term safety and benefits of FDA-approved treatments

Getting Started Today

  1. Talk to your oncologist about clinical trials at your first appointment
  2. Get genetic testing (both of your normal cells and tumor cells) early—this opens up more trial options
  3. Search online using the resources above
  4. Ask for a second opinion from an academic cancer center
  5. Keep copies of your molecular profiling report and [ID removed] to share with trial coordinators

Important Reminder

According to Let's Win Pancreatic Cancer, "Don't wait for your doctor to bring up clinical trials. Start the conversation and learn about all of your treatment options." You can leave a trial at any time and seek other treatment, so participation is your choice.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: